MedPath

Amiloride Hydrochloride and Hydrochlorothiazide

Amiloride Hydrochloride and Hydrochlorothiazide Tablets, USP

Approved
Approval ID

8b2c581a-f955-4a8e-bf85-e768e903fd10

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 27, 2022

Manufacturers
FDA

Teva Pharmaceuticals USA, Inc.

DUNS: 001627975

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Amiloride Hydrochloride and Hydrochlorothiazide

PRODUCT DETAILS

NDC Product Code0555-0483
Application NumberANDA071111
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateDecember 27, 2022
Generic NameAmiloride Hydrochloride and Hydrochlorothiazide

INGREDIENTS (9)

AMILORIDE HYDROCHLORIDEActive
Quantity: 5 mg in 1 1
Code: FZJ37245UC
Classification: ACTIR
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
HYDROCHLOROTHIAZIDEActive
Quantity: 50 mg in 1 1
Code: 0J48LPH2TH
Classification: ACTIB
D&C YELLOW NO. 10 ALUMINUM LAKEInactive
Code: CQ3XH3DET6
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
ALUMINUM OXIDEInactive
Code: LMI26O6933
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MAGNESIUM OXIDEInactive
Code: 3A3U0GI71G
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Amiloride Hydrochloride and Hydrochlorothiazide - FDA Drug Approval Details